Condition: Appropriate and Inappropriate Shock Therapy With ICD · Arrhythmias Detection · Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
The study is a prospective multicenter registry. Consecutive patients with indications of implant / replacement or upgrade of implantable cardioverter defibrillator (ICD) will be enrolled. The primary objective of the study is to determine the predictors of appropriate anti-tachycardia therapy (with shock) in a non-selected population of patients implanted with an ICD. Secondary objectives of the study are: * the incidence of anti-tachycardia therapies; * the predictors of inappropriate therapy and onset of arrhythmia burden; * the adherence to the current guidelines in the Italian clinical practice; * the predictors of heart failure (HF) onset and response to cardiac resynchronization therapy (CRT).
This description comes directly from the study's public registry record.
Alessandro Vicentini, MD · 0382.503715 · clinical-estimate@isis.it
Always discuss trial participation with your own doctor first.
| Ospedale Papa Giovanni XXIII | Bergamo, Italy | Recruiting |
| Policlinico S.Orsola-Malpighi | Bologna, Italy | Recruiting |
| P.O. Rodolico-San Marco | Catania, Italy | Recruiting |
| Azienda Ospedaliero Universitaria Careggi | Florence, Italy | Recruiting |
| ASST Rhodense- Ospedale di Rho | Milan, Italy | Recruiting |
| IRCCS S.Ambrogio-Galeazzi | Milan, Italy | Recruiting |
| Ospedale dei Colli Monaldi | Naples, Italy | Recruiting |
| University of Padua | Padua, Italy | Recruiting |
| IRCC Policlinico San Matteo | Pavia, Italy | Recruiting |
| Azienda Ospedaliero Universitaria Pisa Cisanello | Pisa, Italy | Recruiting |
| Azienda Ospedaliera S.Andrea | Rome, Italy | Recruiting |
| Ospedale Bambino Gesù | Rome, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02275637